On November 8, 2019 Orexo AB (publ), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, reported that the company will present at the Jefferies Healthcare Conference on Wednesday, November 20, 2019, at 10.40 am GMT at the Waldorf Hilton Hotel in London, UK (Press release, Orexo, NOV 8, 2019, View Source [SID1234550773]). President and CEO, Nikolaj Sørensen, will provide an update on Orexo’s market, sales development, pipeline progression and the growth strategy, focusing on broadening the product portfolio and building a presence in the increasingly important and complementary digital therapeutics market.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The presentation will be made available at Orexo’s website, www.orexo.com, under the Investor section.
For further information, please contact
Orexo AB (publ.)
Lena Wange, IR and Communications Manager
Tel: +46 (0)18-780-88-00
E-mail: [email protected]